Moneycontrol PRO
serum institute
Jump to
45 Results Found
  • PM Modi in TIME Magazine's '100 Most Influential People 2021' list; Mamata Banerjee, Adar Poonawalla also feature Sep 15, 2021 09:15 PM IST

    PM Modi in TIME Magazine's '100 Most Influential People 2021' list; Mamata Banerjee, Adar Poonawalla also feature

    While featuring PM Modi in the influential people's list, TIME called him the third pivotal leader of independent India after Jawaharlal Nehru and Indira Gandhi who "dominated the country’s politics like no one since them."

  • Serum Institute buys 50% stake in pharma packaging firm Schott Kaisha Aug 17, 2021 02:34 PM IST

    Serum Institute buys 50% stake in pharma packaging firm Schott Kaisha

    Serum Institute has acquired stake from former co-owners Kairus Dadachanji and Shapoor Mistry, Schott and Serum Institute of India said in a joint statement.

  • Magma Fincorp is now Poonawalla Fincorp after takeover by Serum Institute CEO Adar Poonawalla Jul 23, 2021 11:42 AM IST

    Magma Fincorp is now Poonawalla Fincorp after takeover by Serum Institute CEO Adar Poonawalla

    Adar Poonawalla is also the Chief Executive Officer of Serum Institute of India, which is manufacturing the Oxford-AstraZeneca vaccine (Covishield) against COVID-19.

  • Serum Institute to raise AstraZeneca COVID-19 vaccine output in June May 31, 2021 10:55 AM IST

    Serum Institute to raise AstraZeneca COVID-19 vaccine output in June

    Owing to vaccine shortage, in March, India had put a temporary hold on all major exports of the AstraZeneca coronavirus vaccine to meet demand at home as infections rise.

  • COVID-19 vaccines | Pune mayor Murlidhar Mohol seeks permission to buy vaccine doses directly from SII May 25, 2021 10:57 PM IST

    COVID-19 vaccines | Pune mayor Murlidhar Mohol seeks permission to buy vaccine doses directly from SII

    He and officials of the Pune Municipal Corporation met SII officials and also wrote to them seeking at least 25 lakh doses for the Pune city.

  • How India’s vaccination drive could play out with the available shots May 19, 2021 05:37 PM IST

    How India’s vaccination drive could play out with the available shots

    By August, suggest some experts, the situation will ease. July is the crucial month when indigenous production of vaccines will go up, as will imports

  • Exclusive | Government has not restricted vaccine makers and will not ban commercial exports, say officials May 19, 2021 02:26 PM IST

    Exclusive | Government has not restricted vaccine makers and will not ban commercial exports, say officials

    As the debate on allowing vaccine exports in the face of local shortage gains momentum, senior officials across key ministries say companies are free to honour their contractual obligations and sell abroad if they have enough doses

  • WHO reminds Serum Institute of its COVAX commitments amidst devastating COVID-19 outbreak, soaring demand in India May 18, 2021 10:33 AM IST

    WHO reminds Serum Institute of its COVAX commitments amidst devastating COVID-19 outbreak, soaring demand in India

    During a daily virtual press briefing on Monday, the World Health Organisation Director-General said that the surge in COVID-19 cases around the world has compromised the global vaccine supply and there is already a shortfall of 190 million doses to COVAX by the end of June.

  • COVID-19 | UP govt amends vaccine tender to make Pfizer, Moderna eligible; Chinese firms need Centre’s nod May 16, 2021 07:55 PM IST

    COVID-19 | UP govt amends vaccine tender to make Pfizer, Moderna eligible; Chinese firms need Centre’s nod

    Global tenders for vaccines issued by the Uttarakhand government and Mumbai’s civic body had also specifically barred companies from neighbouring countries.

  • As vaccines become scarce, states adopt different strategies to secure supplies May 13, 2021 06:22 PM IST

    As vaccines become scarce, states adopt different strategies to secure supplies

    While some municipalities are, or will issue tenders to procure vaccines, others are directly talking to manufacturers. The smaller provinces seem to be depending on distribution by the central government.

  • Covid vaccine production and availability: What we know so far May 04, 2021 02:23 PM IST

    Covid vaccine production and availability: What we know so far

    So far, 15.5 crore doses have been administered since January and the central and state governments along with the private sector aim to get 30 crore more doses in three months until July.

  • Vaccination deals between Serum Institute, Bharat Biotech and states: What we know so far Apr 29, 2021 11:51 AM IST

    Vaccination deals between Serum Institute, Bharat Biotech and states: What we know so far

    COVID-19 Second Wave Vaccine Drive: It has been a Covishield show so far as state governments make a beeline for developer SII’s office. Bharat Biotech needs to significantly ramp up capacity of Covaxin.

  • Centre should share some financial burden of states' vaccine procurement, experts say Apr 25, 2021 06:46 PM IST

    Centre should share some financial burden of states' vaccine procurement, experts say

    Former CEA Arvind Subramanian said that centre should bear entire cost of vaccine procurement by state. Other economists partly agree and say that part of the Rs 35,000 crore vaccination budget should be shared with states

  • COVID-19 Vaccine | Serum Institute issues clarification on Covishield pricing, says govt procurement is at 'far lower price' Apr 24, 2021 04:18 PM IST

    COVID-19 Vaccine | Serum Institute issues clarification on Covishield pricing, says govt procurement is at 'far lower price'

    "Covishield is the most affordable COVID-19 vaccine available in the market today. The initial prices were kept very low globally as it was based on advance funding given by those countries for at-risk vaccine manufacturing," Serum India said in a statement.

  • Explained | How the new vaccination drive is expected to roll out Apr 23, 2021 11:16 AM IST

    Explained | How the new vaccination drive is expected to roll out

    On April 19, the central government announced a major shift in its Covid-19 vaccination strategy. Moneycontrol takes a look at what these changes mean.

  • COVID-19 vaccine | Serum Institute's Covishield priced at Rs 400 per dose for states; Rs 600/dose for private hospitals Apr 21, 2021 12:42 PM IST

    COVID-19 vaccine | Serum Institute's Covishield priced at Rs 400 per dose for states; Rs 600/dose for private hospitals

    Serum Institute of India said 50 percent of its capacities will serve the Centre's COVID-19 vaccination programme, and the remaining 50 percent will be for state governments and private hospitals.

  • COVID-19 update | UNICEF says AstraZeneca supply issues outside India resolved Apr 20, 2021 08:39 PM IST

    COVID-19 update | UNICEF says AstraZeneca supply issues outside India resolved

    UNICEF also expects to receive 50 million doses of the shot from the Serum Institute of India in May, compared with almost none this month as the company tries to meet demand in its home country that is battling a huge jump in infections.

  • Serum Institute of India refunds South Africa for undelivered COVID-19 vaccines Apr 09, 2021 08:08 AM IST

    Serum Institute of India refunds South Africa for undelivered COVID-19 vaccines

    A million doses from the institute, which had already been delivered, have been sold on to other countries in the African Union.

  • Network18 Sanjeevani launch | Exploring possibility of third dose but no official recommendation: Serum Institute CEO Adar Poonawala Apr 07, 2021 01:19 PM IST

    Network18 Sanjeevani launch | Exploring possibility of third dose but no official recommendation: Serum Institute CEO Adar Poonawala

    Serum Institute CEO Adar Poonawala was speaking at the launch of the Network18 Sanjeevani – A Shot Of Life, a CSR initiative by Federal Bank.

  • Delhi HC asks Serum Institute, Bharat Biotech to disclose capacity to manufacture COVID-19 vaccines Mar 04, 2021 03:09 PM IST

    Delhi HC asks Serum Institute, Bharat Biotech to disclose capacity to manufacture COVID-19 vaccines

    The high court also asked the Centre to explain in affidavit the rationale behind keeping strict control over class of persons who can be vaccinated against COVID-19 currently as under the present system those above the age of 60 years or between 45 to 60 years with comorbidities can receive vaccination.

  • COVID-19 vaccine tracker| India may emerge as second largest vaccine maker after the US: Report Feb 15, 2021 06:44 PM IST

    COVID-19 vaccine tracker| India may emerge as second largest vaccine maker after the US: Report

    Prior to COVID-19 pandemic, India had been producing 60 percent of the world's vaccines for various diseases at an affordable rate.

  • Serum Institute of India delays vaccines for private sale in Bangladesh; focus on state campaigns Feb 04, 2021 02:42 PM IST

    Serum Institute of India delays vaccines for private sale in Bangladesh; focus on state campaigns

    Beximco is Bangladesh's exclusive distributor of the Oxford University-AstraZeneca shot that SII, the world's biggest vaccine manufacturer, is producing in bulk for low- and medium-income countries.

  • COVID-19 vaccine export may start in 2 weeks, says Serum Institute CEO Adar Poonawalla Jan 18, 2021 09:13 AM IST

    COVID-19 vaccine export may start in 2 weeks, says Serum Institute CEO Adar Poonawalla

    Serum Institute's Chief Executive Officer Adar Poonawalla said that exports of the COVID-19 vaccine doses will start only after local requirements are fully met.

  • COVID vaccine expected to arrive early next week in Delhi, immunisation preparations underway Jan 06, 2021 10:17 PM IST

    COVID vaccine expected to arrive early next week in Delhi, immunisation preparations underway

    The city government is creating a massive storage facility at the Rajiv Gandhi Super Speciality Hospital (RGSSH) and the police administration has been informed about the imminent arrival of the vaccine lot.

  • Serum Institute gets ahead in COVID-19 vaccine, but opportunity still exists for others Jan 06, 2021 09:03 AM IST

    Serum Institute gets ahead in COVID-19 vaccine, but opportunity still exists for others

    Serum Institute alone cannot inoculate the entire population at one go. This leaves enough space for competitor vaccines, provided they succeed in clinical trials

Sections
ISO 27001 - BSI Assurance Mark